Oxford Surgeon Bob Marshall - Qualifications, Publications

Bob Marshall CV / Publications

Qualifications

MS	University of London	1999
FRCS	Royal College of Surgeons, London	1992
MB BS	St Thomas' Hospital Medical School	1988

Affiliations to Professional Bodies

Royal College of Surgeons
Association of Upper Gastrointestinal Surgeons
General Medical Council 3299551
Medical Protection Society

Previous Appointments

2000 – 2001	Locum Consultant Surgeon, Princess Royal Hospital, Haywards Heath
1997 – 2000	Senior Registrar, South-East Thames Rotation (Ashford, Maidstone, Guy’s Hospital)
1995.1997	Lecturer / Honorary Registrar in General Surgery Guy's Hospital, London
1992.1995	1992.1995 Registrar, South-East Thames Rotation (Brook Hospital, Lewisham, Bromley)

Peer Review Publications

Marshall REK. The South-East Thames continuum training scheme. Surgery 1993;11:11

Marshall REK, Steger AC, Delicata RD, Wafula JMC, Brunell CL, Wyatt AP. Does pre-scan oxygen improve ultrasound visualisation of the pancreas? Clin Rad 1995;50:26-8.

Tyrrell MR, Rocker M, Marshall REK, Taylor PR, Negus D. A randomised trial to compare standard and invagination stripping of the long saphenous vein. Phlebologie 1995;10(suppl 1 vol1):451-3.

Marshall REK, Anggiansah A, Owen WA, Owen WJ. The relationship between acid and bile reflux episodes and symptoms in gastro-oesophageal reflux disease. Gut 1997;40:182-7.

Marshall REK, Anggiansah A, Owen WJ. Bile in the oesophagus: clinical relevance and ambulatory detection. Br J Surg 1997;84:21-8.

Marshall REK, Owen WJ. Proton pump inhibitors in gastro-oesophageal reflux: how much and for how long? Prescriber 1997;8(8):19-22.

Anggiansah A, Taylor G, Marshall REK, Bright NF, Owen WA, Owen WJ. Oesophageal motor responses to gastro-oesophageal reflux in reflux patients compared to healthy controls. Gut 1997;41:600-5.

Marshall REK, Anggiansah A, Owen WA, Owen WJ. The temporal relationship between oesophageal bile reflux and pH in gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol 1998;10(5):385-92.

Anggiansah A, Taylor G, Marshall REK, Bright NF, Owen WA, Owen WJ. What is normal oesophageal motility? An ambulatory study. Scan J Gastroenterol 1998;33:473-83.

Marshall REK, Anggiansah A, Manifold DK, Owen WA, Owen WJ. The effect of Omperazole 20 mg bd on duodeno-gastric and gastro-oesophageal reflux in Barrett’s oesophagus. Gut 1998;43(5):603-6.

Marshall REK, Anggiansah A. Ambulatory bilirubin monitoring. Newwave 1998;1:1-2.

Marshall REK, Anggiansah A, Owen WA, Owen WJ. Investigation of oesophageal reflux symptoms after gastric surgery with combined pH and bilirubin monitoring. Br J Surg 1999;86:271-5.

Chinyama CN, Marshall REK, Owen WJ, Mason RC, Kothari D, Wilkinson ML, Sanderson J. Expression of MUC1 and MUC2 mucin gene products in Barrett’s metaplasia, dysplasia and adenocarcinoma: an immunopathological study with clinical correlation. Histpathology 1999; 35(6):517-24.

Marshall REK, Anggiansah A, Anggiansah CL, Owen WA, Owen WJ. Oesophageal body length, position and pressure in health and disease. Dis Oesoph 1999;12(4):297-302.

Manifold DK, Marshall REK, Anggiansah A, Owen WJ. The effect of Omeprazole on antral duodenogastric reflux in Barrett’s oesophagus. Scand J Gastroenterol 2000;35(8):796-801.

Marshall REK, Anggiansah A, Owen WA, Owen WJ. Investigation of GORD in patients with an intact stomach: is oesophageal bilirubin monitoring a useful addition to pH monitoring? Scand J Gastroenterol 2000;35(9):904-9.

Marshall REK, Anggiansah A, Owen WA, Manifold DK, Owen WJ. The extent of duodenogastric reflux in gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol 2001;13(1):5-10.

Manoifold DK, Anggiansah A, Marshall REK, Owen WJ. Reproducibility and intragastric variation of duodenogastric reflux using ambulatory bilirubin monitoring. Dig Dis Sci 2001;46(1):78-85.

Gillies RS, Simpkin A, Sgromo B, Marshall REK, Maynard ND. Left thoraco-abdominal esophagectomy: results from a single specialist center. Dis Oesoph 2011;24(3):138-44.

Gillies RS, Middleton MR, Han C, Marshall REK, Maynard ND, Bradley KM, Gleeson FV. Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma. Br J Surg 2012 Feb;99(2):239-45.

Gillies RS, Middleton MR, Blesing C, Patel K, Warner N, Marshall REK, Maynard ND, Bradley KM, Gleeson FV. Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer. Eur Rad 2012;22(9):2035-43.

Book Chapter

Anggiansah A, Marshall REK. Use of the oesophageal laboratory. In: Practical management of oesophageal disease. Adams A, Mason RC, Owen WJ eds. Isis Medical 2000; 35-52.

MS Thesis

Marshall REK. Duodenal contents in reflux disease: an investigation using fibreoptic bilirubin monitoring. University of London 1999.

Published Letters

Marshall REK, Tyrrell MR, Treatment of venous ulcers with aspirin. Lancet 1994;334:1513.

Marshall REK, Anggiansah A. Ambulatroy oesophageal bile reflux monitoring in Barrett’s oesophagus. Br J Surg 1996;83:425.

Marshall REK, Owen WJ. The consequences of using different Bilitec tresholds in the analysis of bile reflux data. Ann Surg 1997;225:135-6.

Anggiansah A, Marshall REK. The mechanisms of acid clearance in reflux patients. Ann J Gastroenterol 1997;92(7):1237.

Marshall REK, McPartlin JF. Laparoscopic stoma formation for faecal diversion. Br J Surg 1998;85(8):1161.

Marshall REK, Anggiansah A, Manifold MK, Owen WJ. Treatment of Barrett’s oesophagus by endoscopic laser ablation and anti-reflux surgery. Ann Surg 1998;228(4):621-2.

Manifold DK, Anggiansah A, Marshall REK, Owen WJ. Oesophageal dysmotility is not associated with poor outcome after laparoscopic Nissen fundoplication. Br J Surg 1999;86:969.

Published Abstracts

Marshall REK, Steger AC, Delicata RD, Wafula JMC, Brunell CL, Wyatt AP. Does pre-scan oxygen improve ultrasound visualisation of the pancreas? Gut 1994;35 (suppl 2):S14

Marshall REK, Anggiansah A, Owen WA, Owen WJ. Oesophageal acid and bile reflux correlate well: no relationship to alkaline pH. Gut 1996;38 (suppl 1):A2.

Marshall REK, Anggiansah A, Owen WA, Owen WJ. Duodenal contents in the oesophagus: are they a major cause of reflux symptoms? Gut 1996;38 (suppl 1):A42.

Marshall REK, Anggiansah A, Owen WA, Owen WJ. Bilitec 2000 absorbance thresholds: a need for international protocols to be set. Gut 1996;38 (suppl 1):A43.

Marshall REK, Anggiansah A, Owen WA, Owen WJ. Oesophageal reflux of duodenal contents correlates well with acid, not alkaline, reflux. Gastroenterology 1996;110 (4):A188.

Anggiansah A, Taylor G, Marshall REK, Bright NF, Owen WA, Owen WJ. Ambulatory oesophageal motility in healthy controls: what is normal and how should the data be analysed? Gastroenterology 1996;110 (4):A624.

Marshall REK, Anggiansah A, Owen WA, Owen WJ. Absorbance threshold values for Bilitec 2000: the need for international uniformity. Gastroenterology 1996;110 (4):A187.

Marshall REK, Anggiansah A, Owen WA, Owen WJ. Duodenal contents in the oesophagus: are they a major cause of reflux symptoms? Gastroenterology 1996;110 (4):A187.

Anggiansah A, Taylor G, Marshall REK, Bright NF, Owen WA, Owen WJ. Oesophageal motor responses to gastro-oesophageal reflux in reflux patients compared to healthy controls. Gastroenterology 1996;110 (4):A51.

Marshall REK, Anggiansah A, Owen WA, Owen WJ. Reduction of gastro-oesophageal reflux by Omeprazole in Barrett’s oesophagus: an initial experience. Gut 1996;39 (suppl 1):A29.

Marshall REK, Anggiansah A, Owen WA, Owen WJ. Supine reflux in Barrett’s oesophagus: the temporal relationship between acid and bile reflux. Gut 1996;39 (suppl 1):A28.

Marshall REK, Anggiansah A, Owen WA, Owen WJ. The role of bile in the genesis of oesophageal reflux symptoms. Gut 1996;39 (suppl 1):A194.

Marshall REK, Anggiansah A, Owen WA, Owen WJ. Bile in the oesophagus. How important is it in patients with an intact stomach? Br J Surg 1997;84 (suppl 1):62.

Marshall REK, Anggiansah A, Owen WA, Owen WJ, McColl I. Omeprazole effectively reduces gastro-oesophageal bile reflux as well as acid reflux. Br J Surg 1997;84:708.

Marshall REK, Anggiansah A, Anggiansah CL, Owen WA, Owen WJ. Oesophageal length, lower oesophageal sphincter length and position with respect to diagnosis. Gastroenterology 1997;112(4):A212.

Marshall REK, Anggiansah A, Owen WA, Owen WJ. The temporal relationship between supine acid, bile and alkaline reflux events in Barrett’s oesophagus and oesophagitis. Gastroenterology 1997;112(4):A212.

Chinyama CL, Marshall REK, Owen WJ. Intestinal metaplasia at the gastro-oesophageal junction in the absence of endoscopic Barrett’s oesophagus. Pathology 1997;42(suppl):30A.

Marshall REK, Anggiansah A, Owen WA, Owen WJ. Is the degree of duodenogastric reflux related to the severity of gastro-oesophageal reflux disease? Gut 1997;41(suppl 3):A101.

Anggiansah A, Marshall REK, Anggiansah CL, Owen WA, Owen WJ. Non-specific oesophageal motility disorder and its relationship to gastro-oesophageal reflux. Neurogastroenterology and Motility 1998;10(suppl1):58.

Chinyama CN, Marshall REK, Owen WJ, Mason RC, Kothari D, Wilkinson ML, Sanderson J. MUC1 and MUC2 mucin gene products in Barrett’s oesophagus and related lesions: a preliminary report. Gut 1998;42 (suppl 1):A15.

Manifold DK, Anggiansah A, Marshall REK, Owen WJ. Intra-gastric variation of duodenogastric reflux. Gut 1998;42 (suppl 1):A71.

Manifold DK, Anggiansah A, Marshall REK, Owen WJ. Intra-subject variability of duodenogastric reflux. Gastroenterology 1998;114(4):A213.

Manifold DK, Anggiansah A, Marshall REK, Owen WJ. Intra-gastric variation of duodenogastric reflux. Gastroenterology 1998;114(4):A212.

Marshall REK, Anggiansah A, Owen WA, Manifold DK, Owen WJ. The effect of Omeprazole 20 mg bd on duodeno-gastric and gastro-oesophageal bile reflux in Barrett’s oesophagus. Gastroenterology 1998;114(4):A216.

Anggiansah A, Marshall REK, Owen WJ. Secondary motor activity, mainly non-peristaltic, in the healthy oesophagus. Gastroenterology 1998;114(4):A712.

Manifold DK, Anggiansah A, Owen WA, Marshall REK, Owen WJ. Bread swallow manometry during acid perfusion manometry in dysphagia. Gut 1999;44 (suppl 1):A109.

Manifold DK, Anggiansah A, Marshall REK, Owen WJ. Effect of Omeprazole on antral duodenogastric reflux in Barrett’s oesophagus. Gut 1999;44 (suppl 1):A112.

Manifold DK, Anggiansah A, Owen WA, Marshall REK, Owen WJ. Bread swallow manometry during acid perfusion manometry in dysphagia. Gastroenterology 1999;116(4):A224.

Manifold DK, Anggiansah A, Marshall REK, Owen WJ. Effect of Omeprazole on antral duodenogastric reflux in Barrett’s oesophagus. Gastroenterology 1999;116(4):A245.

R Gillies, Marshall REK, Maynard ND. The Merendino procedure in Oxford: early experience and lessons learnt. Br J Surg 2008 (AUGIS presentation)

R Gillies, Marshall REK, Maynard ND. Is chest radiography necessary following chest drain removal after transthoracic oesophagectomy? Br J Surg 2009 (Augis presentation)

Barnabas A, Bailey AA, Sgromo B, Maynard ND, Marshall RE, Braden B. Diagnostic role of endoscopic ultrasound in selecting patients with early Barrett’s neoplasia for endoscopic therapy. Gut 2011 (BSG11-ABS-2162)

Selvarajah U, Al-Mamari S, Bailey AA, Sgromo B, Marshall REK, Maynard ND, Braden B. Endoscopic mucosal resection for early neoplasia in Barrett’s epithelium in patients on anticoagulation using warfarin: is it safe? Gut (DDF 2012)